Search This Blog

Monday, August 12, 2024

Oragenics Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

 ONP-002 showed no cancer-causing DNA damage

– Phase II clinical trial being planned

https://www.globenewswire.com/news-release/2024/08/12/2928386/0/en/Oragenics-Inc-Announces-Concussion-Drug-Successfully-Completes-FDA-Required-Genotoxicity-Study.html

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)